Lineagen hopes to use PWNHealth's consumer-oriented model to expand access to its testing services for developmental delay and autism spectrum disorder.
The effort could lead to Metafora's flow cytometry-based assay becoming the standard of care for diagnosing the disease in France.
In the long run, genome-wide DNA methylation profiling could be useful in diagnosing constitutional disorders as well as cancer.
